PROGNOSTIC IMPACT OF BIOPSY GLEASON SCORE VARIANTS IN GRADE GROUP 5 PROSTATE CANCER (4+5 VS. 5+4 VS. 5+5): A LARGE COHORT STUDY OF PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY

Presenter(s)

• 

  YU OZAWA, n/a

  CLINICAL FELLOW
  ADVENTHEALTH GRI, United States

Author(s)

• MM

  Marcio Covas Moschovas

  Research Coordinator
  AdventHealth Global Robotics Institute
  kissimee, Florida, United States
• RS

  Rohan Sharma, n/a

  Senior Clinical Fellow
  AdventHealth Global Robotics Institute, United States
• SS

  SHADY SAIKALI, MD

  CLINICAL FELLOW
  ADVENTHEALTH GRI, United States
• MS

  Marco Sandri, MD

  Urology Department and Robotic Surgery
  University of Brescia, United States
• TR

  Travis Rogers, n/a

  Robotic Surgeon
  AdventHealth Global Robotics Institute, United States
• 

  Vipul R. Patel, MD

  Urology department and robotic Surgery
  AdventHealth Global Robotics Institute, Florida, United States